2.965USD+0.17%Mkt Cap: 324.85M USDP/E: —Last update: 2026-05-26
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases i…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap324.85M USD
Enterprise Value219.98M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-223.12M USD
Revenue/Share—
Last Price2.965 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees202
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS77313F1066
Valuation
P/E (Trailing)—
P/E (Forward)-2.68
PEG—
EV/EBITDA-1.09
EV/Revenue—
P/S—
P/B1.43
EPS (TTM)-1.87
EPS (Forward)-1.16
52W Range
2.19018% of range6.430
52W High6.430 USD
52W Low2.190 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-80.49%
ROA-67.52%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-190.01M USD
CapEx (TTM)440.00K USD
FCF Margin—
FCF Yield-30.43%
Net Debt-119.62M USD
Net Debt/EBITDA0.59
Balance Sheet
Debt/Equity0.09
Current Ratio6.12
Quick Ratio5.90
Book Value/Sh2.181 USD
Cash/Share1.322 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 5, 2018
Splits
Last Split1:4
Split DateJan 5, 2018
Analyst Consensus
Rating2.5 (Buy)
Target (Mean)9.295 USD
Target Range3.000 USD – 16.00 USD
# Analysts11
Ownership
Shares Out.109.19M
Float87.64M
Insiders2.95%
Institutions89.92%
Short Interest
Short Ratio7.9d
Short % Float24.22%
Short % Out.19.74%
Shares Short21.55M
Short (prev mo.)18.58M
Technical
SMA 503.770 (-21.4%)
SMA 2003.573 (-17.0%)
Beta0.52
S&P 52W Chg28.31%
Avg Vol (30d)2.18M
Avg Vol (10d)2.51M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—